Founded in 2012, PECA Labs®, Inc. is a Carnegie Mellon University and University of Pittsburgh Spin-off Focused on the Pediatric and Cardiovascular Surgical Device Spaces.

PECA Labs® now has a suite of disruptive products in development, which are intended to provide significantly improved outcomes for children born with rare congenital heart defects.

  • exGraft

    exGraft is a CE-Marked Synthetic Vascular Graft. exGraft fuses the performance of ePTFE with the addition of a novel radiopaque design. This first-in-class combination enhances the visibility of graft location and orientation during surgery and follow-up. The graft can be balloon expanded up to 140% of its original size.

    See Product